3-MeO-PCPr Stats & Data

3-MeO-PCPr is a potent, understudied arylcyclohexylamine; individual sensitivity varies markedly, so cautious titration is essential. Effects can feel deceptively functional and stimulating compared with ketamine, which increases the risk of ambulatory delirium, mania, and hazardous decision-making at higher doses. Start with a low allergy test (≤1 mg) and wait a full onset window before any redose; redosing during the come-up is a common route to overdosing on 3-MeO–substituted compounds. Because accurate weighing below ~10 mg is difficult for many consumer scales, volumetric dosing is strongly recommended to prevent accidental multi‑x dosing. Expect a long tail; residual stimulation, disequilibrium, and afterglow can persist into the next day, so avoid driving or safety‑critical tasks for at least 12–24 hours after significant dosing. Mixing with CNS depressants (alcohol, benzos, opioids) increases accident risk and can compound sedation or blackouts despite a ‘stimulating’ body feel. Combining with stimulants or psychedelics substantially raises the likelihood of anxiety, delusional thinking, and psychosis; several case narratives with 3‑MeO‑PCP analogues report extreme psychosis at strong doses and when mixed. As with other dissociatives, repeated or heavy use may contribute to lower urinary tract symptoms (urgency, pain, frequency); reduce frequency, hydrate, and discontinue if symptoms emerge. Substitution/mislabeling is common in the dissociative market—use professional drug checking where available; reagent kits have limitations for this class. Intranasal use can be harsh: finely crush, use small lines, and irrigate with isotonic saline before/after to limit mucosal injury. Tolerance to dissociatives builds rapidly and can persist for days to weeks; cross‑tolerance is expected across arylcyclohexylamines. Those with a history of bipolar disorder or psychosis should avoid due to the elevated mania/psychosis risk.